372 related articles for article (PubMed ID: 34204158)
21. miR-188-5p suppresses cellular proliferation and migration via IL6ST: A potential noninvasive diagnostic biomarker for breast cancer.
Wang M; Zhang H; Yang F; Qiu R; Zhao X; Gong Z; Yu W; Zhou B; Shen B; Zhu W
J Cell Physiol; 2020 May; 235(5):4890-4901. PubMed ID: 31650530
[TBL] [Abstract][Full Text] [Related]
22. Tumor microRNA expression profiling identifies circulating microRNAs for early breast cancer detection.
Matamala N; Vargas MT; González-Cámpora R; Miñambres R; Arias JI; Menéndez P; Andrés-León E; Gómez-López G; Yanowsky K; Calvete-Candenas J; Inglada-Pérez L; Martínez-Delgado B; Benítez J
Clin Chem; 2015 Aug; 61(8):1098-106. PubMed ID: 26056355
[TBL] [Abstract][Full Text] [Related]
23. Identification of miRNAs Enriched in Extracellular Vesicles Derived from Serum Samples of Breast Cancer Patients.
Ozawa PMM; Vieira E; Lemos DS; Souza ILM; Zanata SM; Pankievicz VC; Tuleski TR; Souza EM; Wowk PF; Urban CA; Kuroda F; Lima RS; Almeida RC; Gradia DF; Cavalli IJ; Cavalli LR; Malheiros D; Ribeiro EMSF
Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31963351
[TBL] [Abstract][Full Text] [Related]
24. Serum microRNA as potential biomarker to detect breast atypical hyperplasia and early-stage breast cancer.
An X; Quan H; Lv J; Meng L; Wang C; Yu Z; Han J
Future Oncol; 2018 Dec; 14(30):3145-3161. PubMed ID: 30220214
[TBL] [Abstract][Full Text] [Related]
25. Circulating status of microRNAs 660-5p and 210-3p in breast cancer patients.
Nashtahosseini Z; Aghamaali MR; Sadeghi F; Heydari N; Parsian H
J Gene Med; 2021 Apr; 23(4):e3320. PubMed ID: 33533518
[TBL] [Abstract][Full Text] [Related]
26. Discovery of potential serum and urine-based microRNA as minimally-invasive biomarkers for breast and gynecological cancer.
Ritter A; Hirschfeld M; Berner K; Jaeger M; Grundner-Culemann F; Schlosser P; Asberger J; Weiss D; Noethling C; Mayer S; Erbes T
Cancer Biomark; 2020; 27(2):225-242. PubMed ID: 32083575
[TBL] [Abstract][Full Text] [Related]
27. A novel panel of blood-based microRNAs capable of discrimination between benign breast disease and breast cancer at early stages.
Sadeghi H; Kamal A; Ahmadi M; Najafi H; Sharifi Zarchi A; Haddad P; Shayestehpour B; Kamkar L; Salamati M; Geranpayeh L; Lashkari M; Totonchi M
RNA Biol; 2021 Nov; 18(sup2):747-756. PubMed ID: 34793290
[TBL] [Abstract][Full Text] [Related]
28. Identification of plasma miR-106a-5p and miR-30a-5p as potential biomarkers for mesangial proliferative glomerulonephritis.
Wang L; Lin J; Yu T; Zuo Q; Shen B; Zhang H; Liu B; Cai D; Mao H; Zhao H; Zou Q; Xiao B
Clin Biochem; 2020 Oct; 84():79-86. PubMed ID: 32673627
[TBL] [Abstract][Full Text] [Related]
29. Circulating plasma microRNA signature for the diagnosis of cervical cancer.
Ma G; Song G; Zou X; Shan X; Liu Q; Xia T; Zhou X; Zhu W
Cancer Biomark; 2019; 26(4):491-500. PubMed ID: 31658043
[TBL] [Abstract][Full Text] [Related]
30. Breast tissue-based microRNA panel highlights microRNA-23a and selected target genes as putative biomarkers for breast cancer.
Eissa S; Matboli M; Shehata HH
Transl Res; 2015 Mar; 165(3):417-27. PubMed ID: 25445205
[TBL] [Abstract][Full Text] [Related]
31. Serum circulating microRNA profiling for identification of potential breast cancer biomarkers.
Mar-Aguilar F; Mendoza-Ramírez JA; Malagón-Santiago I; Espino-Silva PK; Santuario-Facio SK; Ruiz-Flores P; Rodríguez-Padilla C; Reséndez-Pérez D
Dis Markers; 2013; 34(3):163-9. PubMed ID: 23334650
[TBL] [Abstract][Full Text] [Related]
32. Predicting the presence of breast cancer using circulating small RNAs, including those in the extracellular vesicles.
Koi Y; Tsutani Y; Nishiyama Y; Ueda D; Ibuki Y; Sasada S; Akita T; Masumoto N; Kadoya T; Yamamoto Y; Takahashi RU; Tanaka J; Okada M; Tahara H
Cancer Sci; 2020 Jun; 111(6):2104-2115. PubMed ID: 32215990
[TBL] [Abstract][Full Text] [Related]
33. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
[TBL] [Abstract][Full Text] [Related]
34. Identification of serum miR-1915-3p and miR-455-3p as biomarkers for breast cancer.
Guo J; Liu C; Wang W; Liu Y; He H; Chen C; Xiang R; Luo Y
PLoS One; 2018; 13(7):e0200716. PubMed ID: 30048472
[TBL] [Abstract][Full Text] [Related]
35. A panel of three serum microRNA can be used as potential diagnostic biomarkers for nasopharyngeal carcinoma.
Li R; Lu C; Yang W; Zhou Y; Zhong J; Chen X; Li X; Huang G; Peng X; Liu K; Zhang C; Hu H; Lai Y
J Clin Lab Anal; 2022 Feb; 36(2):e24194. PubMed ID: 35028969
[TBL] [Abstract][Full Text] [Related]
36. Circulating serum exosomal miR-20b-5p and miR-3187-5p as efficient diagnostic biomarkers for early-stage non-small cell lung cancer.
Zhang ZJ; Song XG; Xie L; Wang KY; Tang YY; Yu M; Feng XD; Song XR
Exp Biol Med (Maywood); 2020 Oct; 245(16):1428-1436. PubMed ID: 32741216
[TBL] [Abstract][Full Text] [Related]
37. Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection.
Schrauder MG; Strick R; Schulz-Wendtland R; Strissel PL; Kahmann L; Loehberg CR; Lux MP; Jud SM; Hartmann A; Hein A; Bayer CM; Bani MR; Richter S; Adamietz BR; Wenkel E; Rauh C; Beckmann MW; Fasching PA
PLoS One; 2012; 7(1):e29770. PubMed ID: 22242178
[TBL] [Abstract][Full Text] [Related]
38. Identification of a circulating microRNA signature to distinguish recurrence in breast cancer patients.
Huo D; Clayton WM; Yoshimatsu TF; Chen J; Olopade OI
Oncotarget; 2016 Aug; 7(34):55231-55248. PubMed ID: 27409424
[TBL] [Abstract][Full Text] [Related]
39. Circulating microRNA-339-5p and -21 in plasma as an early detection predictors of lung adenocarcinoma.
Sun Y; Mei H; Xu C; Tang H; Wei W
Pathol Res Pract; 2018 Jan; 214(1):119-125. PubMed ID: 29103767
[TBL] [Abstract][Full Text] [Related]
40. Breast invasive ductal carcinoma diagnosis with a three-miRNA panel in serum.
Chen X; Li X; Wang J; Zhao L; Peng X; Zhang C; Liu K; Huang G; Lai Y
Biomark Med; 2021 Aug; 15(12):951-963. PubMed ID: 34293926
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]